P
Philippe Maingon
Researcher at University of Paris
Publications - 261
Citations - 17363
Philippe Maingon is an academic researcher from University of Paris. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 49, co-authored 238 publications receiving 14930 citations. Previous affiliations of Philippe Maingon include European Organisation for Research and Treatment of Cancer & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
Cancer de l'endomètre de stade I
TL;DR: Recent data suggest that vaginal brachytherapy is effective in preventing vaginal recurrence with lower toxicity and should be the treatment of choice for intermediate risk endometrial cancer.
Journal ArticleDOI
French study of dose escalation from 66 to 80 GY with 3D-CRT in prostate cancer: results at 5 years
Pierre Bey,Christian Carrie,Chantal Ginestet,Pierre Aletti,P. Pommier,D. Cowen,Laurence Gonzague-Casabianca,M Simonin-Sauve,Philippe Maingon,S. Naudy,Jean-Léon Lagrange,Serge Marcie +11 more
Journal ArticleDOI
Exclusive radiotherapy for non-small cell lung cancer. A retrospective multicentric study
D Gouders,Philippe Maingon,Marianne Paesmans,P. Rodrigus,B. Hahn,M.D. Arnaiz,T. Nguyen,C. Landmann,J.F. Bosset,S. Danhier,P. Van Houtte +10 more
TL;DR: Poor data outlined the needs for better radiation technique and for a better staging system for early inoperable lung cancer.
Journal ArticleDOI
Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse
Coraline Bednarek,Gilles Créhange,Magali Quivrin,Adèle Cueff,Noémie Vulquin,Cédric Chevalier,Thomas Cerda,Yolande Petegnief,F. Mazoyer,Philippe Maingon,Jean François Bosset,Stephanie Servagi Vernat +11 more
TL;DR: Loco-regional failure after exclusive chemoradiotherapy for esophageal cancer may be due to an inadequately low dose.
Journal ArticleDOI
Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer
Céline Mirjolet,Paul Walker,Mélanie Gauthier,C. Dalban,S. Naudy,F. Mazoyer,Etienne Martin,Philippe Maingon,Gilles Créhange +8 more
TL;DR: The absolute volume of the rectum between 25Gy and 50Gy and rAUC25–50 could significantly predict any acute rectal toxicity in prostate cancer patients treated with daily IG-IMRT.